The Preuss Foundation Seminar on the Pathologic Classification of Glial Neoplasms
December 7-8, 1990
Cambridge, Massachusetts
Darell Bigner, M.D., Ph.D. - Chairperson
Duke University Medical Center
Durham, North Carolina
Thomas Brent, Ph.D.
St. Jude Children's Research Hospital
Memphis, Tennessee
Peter C. Burger, M.D.
Duke University Medical Center
Durham, North Carolina
Peter Collins, M.D.
Karolinska Institute
Stockholm, Sweden
Carmine Coscia, Ph.D.
St. Louis University Hospital
St. Louis, Missouri
Richard David, M.D.
University of California, San Francisco
San Francisco, California
Henry M. Furneaux, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York
Mark A. Israel, M.D.
University of California, San Francisco
San Francisco, California
Frank E. Johnson, M.D.
St. Louis University Hospital
St. Louis, Missouri
John Kemshead, M.D.
Frenchay Hospital
Bristol, United Kingdom
Paul Kleihues, M.D.
University of Zurich
Zurich, Switzerland
M. Stephen Mahaley, Jr., M.D., Ph.D.
Maggie Valley, North Carolina
Sankar Mitra, M.D.
University of Tennessee
Oak Ridge, Tennessee
Mark Noble
Ludwig Institute for Cancer Research
London, United Kingdom
Kalpana Patel, M.D.
Frenchay Hospital
Bristol, United Kingdom
Jerome Posner, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York
Lucy Rorke, M.D.
University of Pennsylvania
Philadelphia, Pennsylvania
Bernd W. Scheithauer, M.D.
The Mayo Clinic
Rochester, Minnesota
David Schiffer, M.D.
University of Torino
Torino, Italy
Robert C. Seeger, M.D.
Children’s Hospital of Los Angeles
Los Angeles, California
Leslie Sobin, M.D.
Armed Forces Institute of Pathology
Washington, District of Columbia
John Q. Trojanowski, M.D, Ph.D.
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Nicholas A. Vick, M.D.
Evanston Hospital
Evanston, Illinois
Carol J. Wikstrand
Duke University Medical Center
Durham, North Carolina